Skip to content
Research Article Open access CC BY 4.0

Peripartum Cardiomyopathy: An Enigma

Jayati Nath

Asian Research Journal of Gynaecology and Obstetrics · pp. 74–79 · Published 7 May 2021

Abstract

Peripartum cardiomyopathy is a rare, potentially life-threatening disorder affecting women in late pregnancy & the postpartum period. In spite of  identification of at-risk demographics, theories on etiology, and new targets of therapy for the entity , it still remains an enigma for obstetricians worldwide. The management of PPCM has been  guideline-based treatment for cardiac failure with reduced ejection fraction. Though many newer studies have reported the efficacy of novel therapies, much more research needs to be done. Here an attempt is being made to review the pathogenesis and diagnosis of  PPCM and discuss some of the newest therapies for this enigmatic entity.

Cardiomyopathy heart failure peripartum cardiomyopathy pregnancy peurperium reduced ejection fraction

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.